Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07307092
Eligibility Criteria:
Inclusion Criteria:
Pregnant women aged 18-45 years
Singleton pregnancy
Gestational age between 16 and 24 weeks at enrollment
Diagnosed with cervical insufficiency and scheduled for or recently undergone cervical cerclage
Willing to receive progesterone therapy and provide written informed consent
Exclusion Criteria:
Multiple pregnancy
Known fetal anomalies
Severe maternal comorbidities (e.g., hypertension, diabetes, cardiac disease)
History of allergy or hypersensitivity to progesterone or related compounds
Contraindications to progesterone use
Women who declined to participate or were non-compliant with follow-upInclusion Criteria:
\-
Exclusion Criteria:
\-
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT07307092
Study Brief:
Protocol Section:
NCT07307092